Cartesian Therapeutics, Inc.

RNAC · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$143,384$160,324$180,434$212,610
Short-Term Investments$0$0$0$0
Receivables$722$354$1,765$872
Inventory$0$0$0$0
Other Curr. Assets$0$2,717$2,921$3,144
Total Curr. Assets$147,260$163,395$185,120$216,626
Property Plant & Equip (Net)$17,366$17,449$15,525$15,447
Goodwill$48,163$48,163$48,163$48,163
Intangibles$150,600$150,600$150,600$150,600
Long-Term Investments$2,000$2,000$2,000$2,000
Tax Assets$0$0$0$0
Other NC Assets$7,286$7,286$7,722$2,187
Total NC Assets$225,415$225,498$224,010$218,397
Other Assets$0$0$0$0
Total Assets$372,675$388,893$409,130$435,023
Liabilities
Payables$2,225$454$2,097$288
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$107$0$0$7,761
Total Curr. Liab.$13,803$12,256$14,998$22,976
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$16,141$0$0
Other NC Liab.$385,989$353,464$405,559$407,716
Total NC Liab.$394,716$379,164$415,921$418,849
Other Liabilities$0$0$0$0
Cap. Leases$12,603$13,349$14,066$13,984
Total Liabilities$408,519$391,420$430,919$441,825
Equity
Pref Stock$0$0$0$0
Common Stock$3$3$3$3
Retained Earnings-$729,797-$693,895-$709,781-$692,071
AOCI-$4,587-$4,577-$4,589-$4,621
Other Equity-$0$0$0$0
Total Equity-$35,844-$2,527-$21,789-$6,802
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$372,675$388,893$409,130$435,023
Net Debt-$143,384-$160,324-$180,434-$212,610